Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laith Jamil

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Gastrointestinal Endoscopy|July 6, 2010
An evaluation of risk factors for inadequate cytology in EUS-guided FNA of pancreatic tumors and lymph nodesPatrick Cleveland, Kanwar Rupinder S Gill, Susan G Coe, et al.
Gastrointestinal Endoscopy|August 24, 2019
ASGE guideline on screening and surveillance of Barrett's esophagus, Bashar Qumseya, Shahnaz Sultan, et al.
Ebiomedicine|January 13, 2019
A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancerRichard Tuli, Stephen L Shiao, Nicholas Nissen, et al.
Endoscopy International Open|September 20, 2021
Impact of COVID-19 on gastroenterology fellowship training: a multicenter analysis of endoscopy volumesSwathi Paleti, Zain A Sobani, Thomas R McCarty, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Gastrointestinal Endoscopy|July 6, 2010
An evaluation of risk factors for inadequate cytology in EUS-guided FNA of pancreatic tumors and lymph nodesPatrick Cleveland, Kanwar Rupinder S Gill, Susan G Coe, et al.
Gastrointestinal Endoscopy|August 24, 2019
ASGE guideline on screening and surveillance of Barrett's esophagus, Bashar Qumseya, Shahnaz Sultan, et al.
Ebiomedicine|January 13, 2019
A phase 1 study of veliparib, a PARP-1/2 inhibitor, with gemcitabine and radiotherapy in locally advanced pancreatic cancerRichard Tuli, Stephen L Shiao, Nicholas Nissen, et al.
Endoscopy International Open|September 20, 2021
Impact of COVID-19 on gastroenterology fellowship training: a multicenter analysis of endoscopy volumesSwathi Paleti, Zain A Sobani, Thomas R McCarty, et al.
Pageof 2